Keyphrases
Antihistamines
100%
Chronic Spontaneous Urticaria
100%
Omalizumab
100%
Hematologic Parameters
100%
Basopenia
10%
No Significant Difference
5%
Lymphocytes
5%
Age-matched
5%
Low-grade Inflammation
5%
Pathophysiologic
5%
Platelets
5%
Monocytes
5%
High-sensitivity C-reactive Protein (hs-CRP)
5%
Mean Platelet Volume
5%
Record Data
5%
Basophils
5%
Retrospective Observational Study
5%
Eosinophils
5%
IgE Levels
5%
C-reactive Protein Level
5%
H1-antihistamines
5%
Basophil Count
5%
Eosinopenia
5%
Total IgE
5%
Electronic Patient Record
5%
Resistance Biomarkers
5%
Medicine and Dentistry
Biological Marker
100%
Chronic Urticaria
100%
Histamine Antagonist
100%
Omalizumab
100%
Lymphocyte
5%
Base
5%
Observational Study
5%
Immunoglobulin E
5%
Platelet
5%
Monocyte
5%
C Reactive Protein
5%
Mean Platelet Volume
5%
Electronic Patient Record
5%
Basophil
5%
Eosinophil
5%
Basophil Cell
5%
H1 Antagonist
5%
Eosinopenia
5%
Nursing and Health Professions
Biological Marker
100%
Antihistaminic Agent
100%
Chronic Urticaria
100%
Omalizumab
100%
Base
5%
Immunoglobulin E
5%
Inflammation
5%
C Reactive Protein
5%
Mean Platelet Volume
5%
Personal Health Record
5%
Histamine H1 Receptor Antagonist
5%
Eosinopenia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Antihistaminic Agent
100%
Omalizumab
100%
Chronic Urticaria
100%
Inflammation
5%
Base
5%
Observational Study
5%
C Reactive Protein
5%
Immunoglobulin E
5%
Histamine H1 Receptor Antagonist
5%
Eosinopenia
5%
Immunology and Microbiology
Chronic Urticaria
100%
Omalizumab
100%
Blood Plasma
10%
Lymphocyte
5%
Monocyte
5%
C-Reactive Protein
5%
Immunoglobulin E
5%
Mean Platelet Volume
5%
Platelet
5%
Basophil Granulocyte
5%
Eosinophil Granulocyte
5%
Basophil
5%
Histamine H1 Receptor Antagonist
5%
Electronic Patient Record
5%